Events: detail
Understanding US-FDA Drug Submission Procedures
- Hosted by:
- PTI Europe
- Speaker:
- None listed
- Starts:
- October 30, 2008 at 09:15 am
- Ends:
- October 31, 2008 at 05:00 pm
- Location:
- Regus Victoria, Portland House, Stag Place, London, SW1 5RS United Kingdom
- Maps:
Description
How can you avoid receiving a FDA non-approvable letter? Do you want to be responsible for delaying your drug submission in the USA because you failed to supply the right registration dossier? In the challenging environment of US drug registrations procedures, you need to understand all the current procedures. To help you do this, IPT has developed this course to clarify the US regulatory process. By attending , you will gain a practical insight into FDA’s requirements for new drug development and prepare your new drug registration dossier accordingly to US guidelines.
- Registration required:
- Yes
- Free:
- No
Additional information
Register online or Call:
Customer Services – PTI
Tel: +44 (0)20 7017 7481
Email: registration@pti-europe.co.uk
For more information
- Contact person:
- PTI Europe
- Phone:
- 020 7017 7481
- Email:
- registration [ at ] pti-europe.co.uk
- Website:
- Understanding US-FDA Drug Submission Procedures
